World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
10469
World Ranking
4591
National Ranking
2070

Xiaoying Shen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Xiaoying Shen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 133 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Xiaoying Shen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Xiaoying Shen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Xiaoying Shen is affiliated with Duke University in the United States and specializes in research within the fields of Immunology and Microbiology as well as Medicine. Their work spans a range of subfields including Immunology, Infectious Diseases, Virology, Molecular Biology, and Radiology, Nuclear Medicine and Imaging. This interdisciplinary focus supports investigations into immune system mechanisms and infectious agents.

The scientist has contributed extensively to studies on HIV research and treatment, SARS-CoV-2 and COVID-19 research, immunotherapy and immune responses, immune cell function and interaction, T-cell and B-cell immunology, monoclonal and polyclonal antibodies research, and COVID-19 clinical research studies.

Frequent publication venues for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS Pathogens
  • npj Vaccines
  • Journal of Virology
  • Frontiers in Immunology

Co-authorship collaborations have been formed with several researchers, notably:

  • David C. Montefiori
  • Georgia D. Tomaras
  • Guido Ferrari
  • Celia C. LaBranche
  • Bette Korber

Key research publications include:

  • "SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines" (2021, Cell Host & Microbe)
  • "Adjuvanting a subunit COVID-19 vaccine to induce protective immunity" (2021, Nature)
  • "Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351" (2021, New England Journal of Medicine)
  • "Defining the risk of SARS-CoV-2 variants on immune protection" (2022, Nature)
  • "Towards a population-based threshold of protection for COVID-19 vaccines" (2021, Vaccine)

Best Publications

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

    Georgia D. Tomaras;Guido Ferrari;Xiaoying Shen;S. Munir Alam

  • SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.

    Xiaoying Shen;Haili Tang;Charlene McDanal;Kshitij Wagh

  • Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.

    Prabhu S. Arunachalam;Alexandra C. Walls;Nadia Golden;Caroline Atyeo

  • Towards a population-based threshold of protection for COVID-19 vaccines

    Unknown

  • Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial

    Raphael Gottardo;Robert T. Bailer;Bette T. Korber;S. Gnanakaran

  • The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120

    Nicos Karasavvas;Erik Billings;Mangala Rao;Constance Williams

  • Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques

    Hui Li;Shuyi Wang;Rui Kong;Wenge Ding

  • Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals

    Georgia D. Tomaras;James M. Binley;Elin S. Gray;Emma T. Crooks

  • Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies

    Wilton B. Williams;Hua Xin Liao;M. Anthony Moody;Thomas B. Kepler

  • Adjuvant-dependent Innate and Adaptive Immune Signatures of Risk of SIVmac251 Acquisition

    Monica Vaccari;Shari N Gordon;Slim Fourati;Luca Schifanella;Luca Schifanella

  • Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.

    Xiaoying Shen;Haili Tang;Rolando Pajon;Gale Smith

  • Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization

    Unknown

  • Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial.

    Susan Zolla-Pazner;Susan Zolla-Pazner;Allan C. deCamp;Timothy Cardozo;Nicos Karasavvas

  • Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion

    Willy M. Bogers;Herman Oostermeijer;Petra Mooij;Gerrit Koopman

  • Mapping SARS-CoV-2 antigenic relationships and serological responses

    Unknown

  • Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

    Sampa Santra;Georgia D. Tomaras;Ranjit Warrier;Nathan I. Nicely

  • Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

    Todd Bradley;Justin Pollara;Sampa Santra;Nathan Vandergrift

  • Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies Identified from a Patient with 2F5-Like Antibodies

    Zhongyu Zhu;Haiyan Rebekah Qin;Weizao Chen;Qi Zhao

  • In Vivo gp41 Antibodies Targeting the 2F5 Monoclonal Antibody Epitope Mediate Human Immunodeficiency Virus Type 1 Neutralization Breadth

    Xiaoying Shen;Robert J. Parks;David C. Montefiori;Jennifer L. Kirchherr

  • HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies

    Genevieve G. Fouda;Nicole L. Yates;Justin Pollara;Xiaoying Shen

  • Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

    Scott D. Neidich;Youyi Fong;Youyi Fong;Shuying S. Li;Daniel E. Geraghty

  • SARS-CoV-2 Variant B.1.1.7 is Susceptible to Neutralizing Antibodies Elicited by Ancestral Spike Vaccines

    Xiaoying Shen;Haili Tang;Charlene McDanal;Kshitij Wagh

Frequent Co-Authors

Georgia D. Tomaras
Georgia D. Tomaras Duke University
David C. Montefiori
David C. Montefiori Duke University
Guido Ferrari
Guido Ferrari Duke University
Barton F. Haynes
Barton F. Haynes Duke University
Celia C. LaBranche
Celia C. LaBranche Duke University
Kevin O. Saunders
Kevin O. Saunders Duke University
Sampa Santra
Sampa Santra Beth Israel Deaconess Medical Center
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
David Venzon
David Venzon National Institutes of Health
Sallie R. Permar
Sallie R. Permar Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often involves complementary healthcare fields that enhance understanding of the immune system and patient care. For those interested in nursing, exploring the easy LPN programs to get into can be a practical first step. Licensed Practical Nurse (LPN) programs offer foundational skills and serve as a gateway into more advanced nursing roles.

Advancing from an LPN, many professionals choose to enroll in easiest online nurse practitioner programs, designed for flexibility and accessibility. These programs enable students to gain specialized knowledge while balancing other commitments, making them ideal for working professionals.

For those focused on mental health within immunology or broader healthcare contexts, online PMHNP programs with clinical placement are crucial. These psychiatric-mental health nurse practitioner programs ensure students receive valuable hands-on experience, fostering practical skills for patient care.

Cost is a significant factor for many students. Identifying cheapest psych NP programs can help aspiring nurse practitioners pursue their education without overwhelming financial burden, making career advancement more attainable.

Best Scientists Citing Xiaoying Shen

Trending Scientists